A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA

NCT05778877 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decided by sponsor

Conditions

Methylmalonic Acidemia (MMA)

Interventions

DRUG: SEL-302

Sponsor

Selecta Biosciences, Inc.

Collaborators

[object Object]